
Xdapa-Met 10/500 Tablet ER
Marketer
Nirvana Healthcare
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Xdapa-Met 10/500 Tablet ER
Dapa-Met Extended-Release 10/500mg tablets combine two medications to manage type 2 diabetes. This treatment helps regulate elevated blood glucose, minimizing the risk of severe diabetic complications and potentially cardiovascular issues. Dapa-Met ER tablets can be taken with food; consistent daily timing improves adherence. Dosage is determined by your physician, and cessation requires medical consultation; abrupt discontinuation can elevate blood sugar, increasing the risk of complications such as kidney disease and vision impairment. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Common side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea), and dehydration is possible; increased fluid intake is recommended. Genital fungal infections are a potential side effect; good hygiene helps prevent this. Prior to initiating treatment, disclose any kidney or liver conditions, urinary tract infections, or diuretic use to your physician. Pregnant or lactating individuals should seek medical advice before starting this medication. Limit alcohol consumption, as it may exacerbate side effects. Regular blood glucose monitoring is crucial while using this medicine.
Uses of Xdapa-Met 10/500 Tablet ER
Managing type 2 diabetes
Major Benefits of Xdapa-Met 10/500 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Xdapa-Met 10/500 Tablet ER. Ingest the tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with a meal.
Common Side effects of Xdapa-Met 10/500 Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Xdapa-Met 10/500 Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Xdapa-Met 10/500 Tablet ER with a meal.
How Xdapa-Met 10/500 Tablet ER works:
Xdapa-Met 10/500 Extended-Release tablets combine dapagliflozin and metformin to effectively manage type 2 diabetes. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. This dual action leads to superior glycemic control.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Xdapa-Met 10/500 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The extended-release Xdapa-Met 10/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Xdapa-Met 10/500 mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Extended-release dapagliflozin/metformin 10/500 mg tablets require careful consideration in individuals with impaired renal function. Dosage modification of dapagliflozin/metformin 10/500 mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Xdapa-Met 10/500 Extended-Release tablets. Dosage modification of Xdapa-Met 10/500 Extended-Release tablets may be necessary. Physician consultation is advised.
What if you forget to take Xdapa-Met 10/500 Tablet ER :
Should you forget to take a Xdapa-Met 10/500 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Xdapa-Met 10/500 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
